Prognostic factors in patients treated with 223Ra: the role of skeletal tumor burden on baseline 18F-fluoride PET/CT in predicting overall survival
EC Etchebehere, JC Araujo, PS Fox… - Journal of Nuclear …, 2015 - Soc Nuclear Med
The purpose of this study was to evaluate outcome after 223Ra dichloride therapy (223Ra)
and to determine whether skeletal tumor burden on whole-body 18F-fluoride PET/CT can be …
and to determine whether skeletal tumor burden on whole-body 18F-fluoride PET/CT can be …
Prognostic factors in patients treated with 223Ra: The role of skeletal tumor burden on baseline 18F-fluoride PET/CT in predicting overall survival
EC Etchebehere, JC Araujo… - Journal of …, 2015 - mdanderson.elsevierpure.com
The purpose of this study was to evaluate outcome after 223 Ra dichloride therapy (223 Ra)
and to determine whether skeletal tumor burden on whole-body 18F-fluoride PET/CT can be …
and to determine whether skeletal tumor burden on whole-body 18F-fluoride PET/CT can be …
[PDF][PDF] Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival
EC Etchebehere, JC Araujo, PS Fox, NM Swanston… - J Nucl …, 2015 - Soc Nuclear Med
The purpose of this study was to evaluate outcome after 223Ra dichloride therapy (223Ra)
and to determine whether skeletal tumor burden on whole-body 18F-fluoride PET/CT can be …
and to determine whether skeletal tumor burden on whole-body 18F-fluoride PET/CT can be …
Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival
EC Etchebehere, JC Araujo, PS Fox… - Journal of nuclear …, 2015 - pubmed.ncbi.nlm.nih.gov
The purpose of this study was to evaluate outcome after (223) Ra dichloride therapy ((223)
Ra) and to determine whether skeletal tumor burden on whole-body (18) F-fluoride PET/CT …
Ra) and to determine whether skeletal tumor burden on whole-body (18) F-fluoride PET/CT …
Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival.
EC Etchebehere, JC Araujo, PS Fox… - Journal of Nuclear …, 2015 - europepmc.org
Methods Forty-two patients with hormone-refractory prostate cancer underwent (223) Ra
and a baseline fluoride PET/CT scan. Fluoride PET/CT parameters were generated …
and a baseline fluoride PET/CT scan. Fluoride PET/CT parameters were generated …
[PDF][PDF] Prognostic factors in patients treated with radium-223: the role of skeletal tumor burden on baseline 18F-fluoride-PET/CT in predicting overall survival
EC Etchebehere, JC Araujo, PS Fox, NM Swanston… - academia.edu
ABSTRACT PURPOSE: To evaluate outcome after radium-223 dichloride therapy (Ra-223)
and to determine if skeletal tumor burden on whole-body 18F-Fluoride-PET/CT can be used …
and to determine if skeletal tumor burden on whole-body 18F-Fluoride-PET/CT can be used …